In HFREF patients, sacubitril/valsartan, given at relatively low doses, does not lead to increased mortality or

R De Vecchis1,2, C Ariano3,4, G Di Biase5

  • 1Preventive Cardiologyand Rehabilitation Unit, DSB 29 "S. Gennaro dei Poveri Hospital", via S.Gennaro dei Poveri 25, 80136, Napoli, Italy. devecchis.erre@virgilio.it.

Herz
|March 10, 2018
PubMed

Insights

Reduced doses of sacubitril/valsartan are safe for heart failure patients intolerant to maximum doses. This approach did not increase mortality or hospitalizations for heart failure compared to target doses.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Heart failure with reduced ejection fraction (HFREF) management involves gradual sacubitril/valsartan titration.
  • Dose reduction or interruption is recommended for patients experiencing tolerability issues.

Purpose of the Study:

  • To estimate the proportion of patients on minimum or intermediate sacubitril/valsartan doses.
  • To compare all-cause mortality and heart failure hospitalizations between patients on optimal and sub-maximum sacubitril/valsartan doses.

Main Methods:

  • Retrospective analysis of 68 HFREF patients on sacubitril/valsartan, beta-blockers, and mineralocorticoid receptor blockers.
  • Identified 20 patients (29.4%) with contraindications for full-dose sacubitril/valsartan.
  • Assessed outcomes in patients maintained on reduced (minimum/intermediate) versus target doses.

Main Results:

  • After a median 5.25-month follow-up, no significant difference in all-cause mortality risk was observed between reduced and target dose groups (OR=1.666, p=0.6266).
  • Patients on reduced sacubitril/valsartan doses showed a similar risk of heart failure hospitalizations compared to those on target doses (OR=0.789, p=1.00).

Conclusions:

  • In HFREF patients intolerant to maximum sacubitril/valsartan doses, reduced doses did not elevate all-cause mortality.
  • Reduced sacubitril/valsartan dosing did not increase heart failure hospitalizations compared to target doses over a median follow-up of 5.25 months.
Abstract

Related Concept Videos

Hospitals-II00:59

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
1.2K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
279
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Hospitals-I01:28

Hospitals-I

Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...
1.7K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
253
Increasing Function01:18

Increasing Function

An increasing function exhibits a rise in output values as input values increase. This behavior is depicted graphically as a curve or line that slopes upward from left to right. Such a function satisfies the condition that if x1 < x2, then f(x1) < f(x2), indicating that the function values grow with increasing inputs. This concept is fundamental in understanding growth trends across various domains, such as population dynamics, financial investments, or resource consumption.The...
403